Hosted on MSN1h
Targeting FGFR mutations offers new hope for bone repair in skeletal disorders
Gain-of-function mutations in fibroblast growth factor receptor (FGFR) genes are known to cause a range of skeletal disorders ...
Synthesis method unlocks a pathway to valuable fluorinated drug compounds for new medicines
Researchers from the National University of Singapore (NUS) have pioneered a new catalytic transformation that converts ...
Verastem Oncology Announces Multiple Data Presentations at Society of Gynecologic Oncology 2025 Annual Meeting on Women’s Cancer
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...
Autophagy malfunction study moves a step closer to understanding Rett syndrome
Rett syndrome is a rare genetic disease affecting 1 in 10,000 newborn girls, characterized by sudden regression around 1 year ...
TMCnet1d
SpringWorks Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business Updates
Continued strong commercial execution of the OGSIVEO launch in the U.S. with fourth quarter and full-year 2024 U.S. net product revenue for OGSIVEO of $61.5 million and $172.0 million, respectively.
Celcuity's High-Stakes Oncology Bet Is Underappreciated
Celcuity's gedatolisib, a dual PI3K/mTOR inhibitor, shows promise in Phase 3 breast cancer trials. Click here to read an ...
Newfound circuit better explains how the brain recognizes what is familiar and important
A newly identified part of a brain circuit mixes sensory information, memories, and emotions to tell whether things are ...
themarijuanaherald5d
Study Finds “Cannabinoids Hold Significant Potential for Preventing and Treating Brain Diseases”
According to a new study published in the journal Cellular Signalling, cannabinoids may play a crucial role in preventing and treating brain diseases by regulating key physiological processes in the ...